Twin Tree Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-94,106
| Closed | -$7.02M | – | 1702 |
|
|
2025
Q1 | $6.82M | Buy |
94,106
+18,284
| +24% | +$1.31M | 0.01% | 805 |
|
|
2024
Q4 | $5.61M | Sell |
75,822
-40,896
| -35% | -$2.86M | 0.01% | 895 |
|
|
2024
Q3 | $7.7M | Buy |
116,718
+109,991
| +1,635% | +$7.99M | 0.02% | 748 |
|
|
2024
Q2 | $621K | Buy |
+6,727
| New | +$596K | ﹤0.01% | 1106 |
|
|
2024
Q1 | – | Sell |
-402,822
| Closed | -$33.8M | – | 1374 |
|
|
2023
Q4 | $30.7M | Buy |
402,822
+364,257
| +945% | +$25.3M | 0.06% | 329 |
|
|
2023
Q3 | $2.67M | Buy |
38,565
+26,575
| +222% | +$2.14M | 0.01% | 822 |
|
|
2023
Q2 | $1.13M | Sell |
11,990
-22,283
| -65% | -$1.94M | ﹤0.01% | 993 |
|
|
2023
Q1 | $2.84M | Sell |
34,273
-96,271
| -74% | -$7.57M | 0.01% | 846 |
|
|
2022
Q4 | $9.74M | Buy |
130,544
+4,219
| +3% | +$325K | 0.02% | 579 |
|
|
2022
Q3 | $10.4M | Sell |
126,325
-304,304
| -71% | -$29.3M | 0.02% | 544 |
|
|
2022
Q2 | $40.9M | Buy |
430,629
+307,632
| +250% | +$31.8M | 0.07% | 226 |
|
|
2022
Q1 | $14.5M | Buy |
+122,997
| New | +$13.8M | 0.02% | 584 |
|
|
2021
Q4 | – | Sell |
-17,114
| Closed | -$2M | – | 1652 |
|
|
2021
Q3 | $1.94M | Buy |
17,114
+11,532
| +207% | +$1.32M | ﹤0.01% | 1037 |
|
|
2021
Q2 | $578K | Buy |
5,582
+3,187
| +133% | +$300K | ﹤0.01% | 1096 |
|
|
2021
Q1 | $200K | Sell |
2,395
-15,569
| -87% | -$1.32M | ﹤0.01% | 1140 |
|
|
2020
Q4 | $1.64M | Buy |
17,964
+17,480
| +3,612% | +$1.45M | 0.01% | 894 |
|
|
2020
Q3 | $39K | Sell |
484
-40,311
| -99% | -$3.15M | ﹤0.01% | 1099 |
|
|
2020
Q2 | $2.82M | Buy |
+40,795
| New | +$2.9M | 0.01% | 800 |
|
|
2020
Q1 | – | Sell |
-16,443
| Closed | -$1.28M | – | 1427 |
|
|
2019
Q4 | $1.28M | Buy |
+16,443
| New | +$1.28M | ﹤0.01% | 813 |
|
|
2019
Q2 | – | Sell |
-376,236
| Closed | -$22.8M | – | 1323 |
|
|
2019
Q1 | $24M | Buy |
376,236
+344,571
| +1,088% | +$19.7M | 0.12% | 144 |
|
|
2018
Q4 | $1.62M | Sell |
31,665
-103,626
| -77% | -$5.24M | 0.01% | 770 |
|
|
2018
Q3 | $7.85M | Buy |
135,291
+45,843
| +51% | +$2.24M | 0.05% | 298 |
|
|
2018
Q2 | $4.34M | Buy |
89,448
+60,309
| +207% | +$2.81M | 0.03% | 466 |
|
|
2018
Q1 | $1.35M | Buy |
+29,139
| New | +$1.27M | 0.01% | 608 |
|
|
2017
Q4 | – | Sell |
-39,594
| Closed | -$1.45M | – | 1045 |
|
|
2017
Q3 | $1.44M | Buy |
39,594
+36,717
| +1,276% | +$1.4M | 0.01% | 621 |
|
|
2017
Q2 | $113K | Buy |
+2,877
| New | +$105K | ﹤0.01% | 838 |
|
|
2016
Q4 | – | Sell |
-50,391
| Closed | -$2.02M | – | 1223 |
|
|
2016
Q3 | $2.02M | Buy |
50,391
+32,583
| +183% | +$1.23M | 0.03% | 496 |
|
|
2016
Q2 | $592K | Sell |
17,808
-50,520
| -74% | -$1.73M | 0.01% | 795 |
|
|
2016
Q1 | $2.01M | Buy |
68,328
+56,490
| +477% | +$1.56M | 0.04% | 421 |
|
|
2015
Q4 | $312K | Sell |
11,838
-29,634
| -71% | -$770K | 0.01% | 996 |
|
|
2015
Q3 | $983K | Buy |
41,472
+22,374
| +117% | +$540K | 0.03% | 554 |
|
|
2015
Q2 | $453K | Buy |
+19,098
| New | +$431K | 0.01% | 900 |
|
|
2015
Q1 | – | Sell |
-39,798
| Closed | -$893K | – | 1197 |
|
|
2014
Q4 | $845K | Buy |
39,798
+24,570
| +161% | +$494K | 0.02% | 638 |
|
|
2014
Q3 | $259K | Buy |
+15,228
| New | +$240K | 0.01% | 806 |
|
|
2013
Q3 | – | Sell |
-61,662
| Closed | -$691K | – | 839 |
|
|
2013
Q2 | $691K | Buy |
+61,662
| New | +$730K | 0.03% | 541 |
|
Other funds holding EW
Twin Tree Management's EW Position: Q2 2025 in Review
Twin Tree Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 94,106 shares — an estimated $7.02M sold.
Twin Tree Management first reported a position in EW in Q2 2013 and held it in 35 quarters. The position peaked at $40.9M in Q2 2022. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Twin Tree Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Twin Tree Management sold 94,106 Edwards Lifesciences shares in Q2 2025, an estimated $7.02M.
- Twin Tree Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 35 quarters.
- Twin Tree Management's Edwards Lifesciences position peaked at $40.9M in Q2 2022.
- 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.